Literature DB >> 8523464

Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy.

C Nakajima-Taniguchi1, H Matsui, S Nagata, T Kishimoto, K Yamauchi-Takihara.   

Abstract

We have searched for mutations in alpha-tropomyosin gene in 50 Japanese patients with hypertrophic cardiomyopathy (HCM) by means of polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis. Two missense mutations of the alpha-tropomyosin gene were detected in Japanese patients with familial HCM. Sequencing analysis revealed a C to T transition at codon 63 leading to a replacement of Ala with Val residue, and a G to A transition with replacement of Asp by Asn at codon 175. These missense mutations were found at residues which were markedly conserved across the species, and have been reported to interact with troponin T. This is the first report on a mutant alpha-tropomyosin gene in a Japanese population. Familial HCM is a genetically heterogeneous disease in Japanese patients, similar to that reported in Caucasian kindreds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523464     DOI: 10.1016/0022-2828(95)90026-8

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  16 in total

Review 1.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

Review 2.  Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.

Authors:  Jil C Tardiff
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

3.  Investigating the effects of tropomyosin mutations on its flexibility and interactions with filamentous actin using molecular dynamics simulation.

Authors:  Wenjun Zheng; Sarah E Hitchcock-DeGregori; Bipasha Barua
Journal:  J Muscle Res Cell Motil       Date:  2016-07-04       Impact factor: 2.698

4.  Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.

Authors:  K Yamauchi-Takihara; C Nakajima-Taniguchi; H Matsui; Y Fujio; K Kunisada; S Nagata; T Kishimoto
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

5.  Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.

Authors:  Robert D Gaffin; Shamim A K Chowdhury; Marco S L Alves; Fernando A L Dias; Cibele T D Ribeiro; Rosalvo T H Fogaca; David F Wieczorek; Beata M Wolska
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-08       Impact factor: 4.733

Review 6.  Alpha-tropomyosin mutations in inherited cardiomyopathies.

Authors:  Charles Redwood; Paul Robinson
Journal:  J Muscle Res Cell Motil       Date:  2013-09-05       Impact factor: 2.698

Review 7.  Thin filament mutations: developing an integrative approach to a complex disorder.

Authors:  Jil C Tardiff
Journal:  Circ Res       Date:  2011-03-18       Impact factor: 17.367

Review 8.  A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.

Authors:  Fan Bai; Li Wang; Masataka Kawai
Journal:  J Muscle Res Cell Motil       Date:  2013-05-23       Impact factor: 2.698

9.  A mouse model of familial hypertrophic cardiomyopathy caused by a alpha-tropomyosin mutation.

Authors:  Rethinasamy Prabhakar; Natalia Petrashevskaya; Arnold Schwartz; Bruce Aronow; Greg P Boivin; Jeffery D Molkentin; David F Wieczorek
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

10.  Defective regulation of contractile function in muscle fibres carrying an E41K beta-tropomyosin mutation.

Authors:  Julien Ochala; Meishan Li; Monica Ohlsson; Anders Oldfors; Lars Larsson
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.